Search results for: 'tech ad condition'

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

Biological age tracking is emerging as a complementary approach to understanding human health, offering a more nuanced assessment of physiological state than chronological age alone. This report examines the evolving landscape of biological aging platforms, with a focus on molecular and omics-based technologies including epigenetic, proteomic, tran...

Remote patient monitoring (RPM) is gaining momentum as a variety of factors create a significant need for the value propositions that RPM promises. The report states that the overall RPM market is expected to increase at a compound annual growth rate of 19.8% from 2017 to 2023. RPM refers to the use of telecommunications technology to enable pat...

Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...

31 Jan 2022  |  North America  |  Market Research

Global Digital Health Investments Growth Opportunities

On-demand Healthcare Services and AI-enabled Care Delivery Enable Future Growth Potential

Infographics

×

Frost & Sullivan observed a significant increase in the digital transformation of healthcare and demand for effective IT solutions to improve care delivery, creating a lot of excitement among investors. Venture capitalist activities in health technology rise as healthcare organizations, clinical trial providers, insurance firms, employers, and poli...

This study charts how digital health ecosystems are likely to form and scale through 2040 and what that implies for providers, payers, technology vendors, and retail/community partners. We define a digital health ecosystem as an interoperable platform that coordinates people, data, and decisions across home, retail, and hospital settings—secured by...

Women’s health is moving beyond single-condition apps and episodic visits toward connected care that follows each life stage—from adolescence to pregnancy and postpartum, through perimenopause and healthy aging. What makes this feasible now is the convergence of policy tailwinds (e.g., expanded postpartum coverage), AI+ at-home diagnostics (earlie...

The World Health Organization (WHO) made the following statement many years ago, “There is no health without mental health”. Today, as the COVID-19 pandemic ravages the world, another public health crisis is looming over our health systems—that of deteriorating mental health. Mass unemployment, salary reductions, depleting financial security nets, ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...